Sero-immunological research in skin disorders of women in the third trimenon.
D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D001327:Autoimmune Diseases; D001787:Blood Group Incompatibility; D006063:Chorionic Gonadotropin / Q000627:therapeutic use; D003429:Cross Reactions; D003874:Dermatitis Herpetiformis / Q000188:drug therapy / Q000276:immunology; D005260:Female; D005333:Fetus / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D010392:Pemphigus / Q000276:immunology; D010920:Placenta / Q000276:immunology; D011247:Pregnancy; D011537:Pruritus / Q000188:drug therapy / Q000276:immunology; D011644:Puerperal Disorders / Q000276:immunology; D012867:Skin / Q000276:immunology; D012871:Skin Diseases / Q000276:immunology*
D006063:Chorionic Gonadotropin; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents